Journal Report

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH

Download PDF
Journal Information
Journal Title
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH
Publisher
BECARIS PUBLISHING
ISSN
2042-6305
E-ISSN
2042-6313
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
The impact of sequential analysis on drug decision-making in Canada
Catherine Beauchemin, Jean Lachaine, Jean-Eric Tarride et al.
2026-10-27
DOI: 10.57264/cer-2026-0171
Cost-effectiveness analysis of nanosecond pulsed field ablation against hemithyroidectomy and total thyroidectomy for benign thyroid nodules
Melissa Gomez Montero, Ralph P. Tufano, Victoria Zaitceva et al.
2026-10-26
DOI: 10.57264/cer-2026-0150
Real-world utilization of pembrolizumab dosing schedules in Belgium: a multi-center retrospective study using a common data model and natural language processing
Annelies Verbiest, Hans Prenen, Annelies Janssens et al.
2026-10-21
DOI: 10.57264/cer-2026-0011
Comparative cost analysis of Eluvia™ versus Zilver <sup>®</sup> PTX <sup>®</sup> in treating femoropopliteal peripheral artery disease utilizing real-world data
Elizabeth A Genovese, Abimbola O Williams, Ryoko Sato et al.
2026-10-21
DOI: 10.57264/cer-2026-0126
Letter to the Editor: Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema
Irmgard Andresen, Natalie Khutoryansky, Sarah L Feeny et al.
2026-10-19
DOI: 10.57264/cer-2026-0018
Corrigendum
2026-10-19
DOI: 10.57264/cer-2026-0215
Response to Letter to the Editor regarding “Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema”
Yinglei Li, Simona Gavata-Steiger, Chiara Nenci et al.
2026-10-19
DOI: 10.57264/cer-2026-0183
Methodological considerations for indirect treatment comparisons of HIV incidence for long-acting injectable pre-exposure prophylaxis
Tristan Curteis, Aidan N Franklin, Rebecca K Judge et al.
2026-10-15
DOI: 10.57264/cer-2026-0103
Real-world cost-effectiveness of sequential therapy of in-class transition to ixazomib versus daratumumab for transplant-ineligible newly diagnosed multiple myeloma in China
Genyong Zuo, Aijun Liu, Zunmin Zhu et al.
2026-10-13
DOI: 10.57264/cer-2026-0146
Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies
Batyrkhan Kuatov, Barkha P Patel, Muhaimen Siddiqui et al.
2026-10-9
DOI: 10.57264/cer-2026-0077
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 31, 2026 16:08